Online inquiry

IVTScrip™ mRNA-Human AGPAT9, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK15913MR)

This product GTTS-WK15913MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AGPAT9 protein. This product can be used in Sertoli cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_024830.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 79888
UniProt ID Q53EU6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AGPAT9, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK15913MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK23657MR IVTScrip™ mRNA-Human ATG2A, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ATG2A
GTTS-WK26999MR IVTScrip™ mRNA-Human ATP5EP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ATP5EP2
GTTS-WK16313MR IVTScrip™ mRNA-Human ALG13, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ALG13
GTTS-WK23121MR IVTScrip™ mRNA-Human APOBEC3D, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA APOBEC3D
GTTS-WK1789MR IVTScrip™ mRNA-Human CYP17, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA CYP17
GTTS-WK7750MR IVTScrip™ mRNA-Human ADH7, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADH7
GTTS-WK8529MR IVTScrip™ mRNA-Human ACLY, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ACLY
GTTS-WK16771MR IVTScrip™ mRNA-Human AOX1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AOX1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →